Bronchopulmonary dysplasia (BPD) is the most common cause of morbidity and mortality in
preterm infants. A key histopathological feature of BPD is stunted late lung development …

With the progress of modern medicine, oxygen therapy has become a crucial measure for
the treatment of premature infants. As an environmental stimulus, in the normal development …

Premature infants are born with developing lungs burdened by surfactant deficiency and a
dearth of antioxidant defense systems. Survival rate of such infants has significantly …

Bronchopulmonary dysplasia is a severe and long-term pulmonary disease in premature
infants. Hyperoxia-induced acute lung injury plays a critical role in bronchopulmonary …

New perinatal care technologies have improved the survival rate of preterm neonates, but
the prevalence of bronchopulmonary dysplasia (BPD), one of the most intractable problems …

Background: Bronchopulmonary dysplasia (BPD) is one of the most common long-term lung
complications of prematurely born infants caused by prolonged injury and repair during …

Bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) is a chronic
infantile lung disease that lacks curative therapies. Infants with BPD-associated PH are often …

The airway epithelium (AE) is the main protective barrier between the host and external
environmental factors causing asthma. Allergens or pathogens induce AE dysfunction …

Background Pseudomonas aeruginosa (PA) is an opportunistic Gram-negative bacterium
that causes serious life threatening and nosocomial infections including pneumonia. PA has …

Bronchopulmonary dysplasia (BPD) is a devastating chronic neonatal lung disease leading
to serious adverse consequences. Nearly 15 million babies are born preterm accounting …